Housing Finance Software Copyright Dispute

/ By / Copyright

This seems to be the season for disputes between competitors, with accusations of data theft and copyright infringement flying around from time to time. Soon after the Burrp-Zomato and Cleartrip-Travelocity disputes, we have another one to report, but this time in the context of housing finance software, with software firm Kensoft Infotech accusing Sundaram BNP Paribas Housing Finance (“Sundaram”) of fraudulent use, criminal breach of trust, hacking, reverse engineering and tampering of their software. In this instance, Kensoft Infotech had […]

Housing Finance Software Copyright Dispute Read More »

DIPP invites suggestions on reforming the Patents & Trademarks office

/ By / Trademark

The Department of Industrial Policy & Promotion (DIPP) has recently released a well-written, ‘discussion paper’ (available here), on the ‘Review of organizational structure of the Office of the Controller General of Patents, Designs, Trade Marks and Geographical Indications’. This ‘discussion paper’ seeks to examine the steps that can be taken to enhance the efficacy of the patents & trademark offices and going by the issues raised in the paper, it does appear that the DIPP is open to making some

DIPP invites suggestions on reforming the Patents & Trademarks office Read More »

Delhi High Court passes ex-parte interim injunction against Symed Labs for alleged infringement of Indian Patent No: 221536

/ By / Uncategorized

In an extremely surprising order, Justice Sistani of the Delhi High Court passed an ex-parte interim injunction, on the 16th of September, 2011 against Symed Laboratories Ltd. in a lawsuit filed by Vifor (International) Ltd., a European Pharmaceutical Company for the violation of its Indian patent no. 221536. It must be noted that the patent has been granted to Vifor (International) AG i.e. the Swiss parent company and not Vifor (International) Ltd, which is the entity that has filed the

Delhi High Court passes ex-parte interim injunction against Symed Labs for alleged infringement of Indian Patent No: 221536 Read More »

ACTA signing begins

/ By / Uncategorized

Today, a ceremony in Tokyo saw the first few countries start to sign the very controversial Anti-Counterfeiting Trade Agreement (ACTA). Though 11 countries took part in the final negotiations last year, 8 of them actually signed it today. Australia, Canada, Japan, Republic of Korea, Morocco, New Zealand, Singapore and the US were the 8 that signed it, while the EU, Mexico and Switzerland have not signed it yet.  The Agreement requires the ratification of 6 members and will come into

ACTA signing begins Read More »

India’s desi AK – 47

/ By / Copyright

India may soon have its desi AK – 47, reportedTimes of India. It is expected to be more potent than the Russian made AK – 47.  As per the report, the weapon which is developed by Tiruchirapalli Ordnance Factory in Tamil Nadu, is undergoing final rounds of evaluation. Not formally christened so far, the weapon is known as Tiruchirapalli Assault Rifle (TAR). The report traced the development of the desiversion back to a Defence Expo in New Delhi in 2000.

India’s desi AK – 47 Read More »

New Franklin Pierce Centre for IP opens at the University of New Hampshire School of Law

/ By / Uncategorized

(Image taken from here)The IP activities in the University of New Hampshire School of Law just got a boost with the new Franklin Pierce Centre for Intellectual Property that is scheduled to be formally inaugurated over September 30 and October 1, 2011. The inaugural ceremony is going to feature among other things a high-profile academic conference on IP and the Innovation System [involving current issues in patents, trademarks, and copyright, as well as property theories and security interests], a panel

New Franklin Pierce Centre for IP opens at the University of New Hampshire School of Law Read More »

Guest Post: Taking a closer look at the Nexavar litigation

/ By / Uncategorized

In April last year we had carried our first post on the Bayer-Cipla litigation. This particular lawsuit was unique because Justice Bhat had fast-tracked the case with some unique innovations. While we have covered the progress in the litigation we have not really covered the arguments being put forth by both the parties to this litigation. In this post, Ms. Taapsi Johri, an experience patent lawyer, who has represented several originator pharmaceutical companies, has written us this in-depth analysis of

Guest Post: Taking a closer look at the Nexavar litigation Read More »

Justice Sridevan’s report exposes the Central Govt’s apathy towards the IPAB

/ By / Uncategorized

C.H. Unnikrishnan of the Mint carried an interesting story, yesterday, on the state of affairs at the IPAB. As most of you may know Shamnad had filed a PIL before the Madras High Court in January of this year against the creation of the IPAB on the grounds that it is unconstitutional for violating the doctrine of separation of powers. A secondary aim of the PIL was to bring urgent attention towards the absolute lack of resources at the IPAB.

Justice Sridevan’s report exposes the Central Govt’s apathy towards the IPAB Read More »

Conducting a post-mortem on Astella’s Indian Patent No: 234753

/ By / Uncategorized

Continuing from my last post on Astella’s patent infringement lawsuit against Micro-Labs, I’ve managed to access the details of the file wrapper from the IPAIRs system and I thought it would be interesting to point out a few of the other issues that may arise in the challenge Astella’s Indian Patent No: 234753. Let me also insert the caveat that the accuracy of this post is directly dependant on the accuracy of the information uploaded on the IPAIRs system and

Conducting a post-mortem on Astella’s Indian Patent No: 234753 Read More »

Japanese pharmaceutical company sues for patent infringement in Delhi to protect its French markets

/ By / Uncategorized

We have recently received information about an interesting patent infringement case filed by Astellas Pharma Europe B.V. (‘Astellas’) a company incorporated in the Netherlands, before the Delhi High Court (C.S. (O.S.) No. 1166 of 2011) against Micro-Labs Ltd., a Bangalore based Indian pharmaceutical company. Despite the distinctly European name of the Plaintiff, it is in reality a subsidiary of a Japanese company, which in itself is the child of a merger between two Japanese companies. For some reason, probably one

Japanese pharmaceutical company sues for patent infringement in Delhi to protect its French markets Read More »

Scroll to Top